Answer
Jinarc (tolvaptan) is not recommended for children and adolescents with ADPKD because its safety and efficacy in this age group have not been established and no data are available.
Sources for this answer
- Jinarc 15mg TabletsOtsuka Pharmaceuticals (UK) Ltd · emc · SmPC §4.2 Posology and method of administration · Version 17Document updated
Sources checked